Skip to main content

Nihon Gene Research Lab to Use CombiMatrix Biochip Synthesizer for Services Business

NEW YORK, April 7 - CombiMatrix, a subsidiary of Acacia Research, said today that it has sold a DNA Microarray Synthesizer to Nihon Gene Research Laboratory (NGRL) in Sendai, Japan.


NGRL plans to use the synthesizer as part of a custom microarray production and analysis service for the Japanese research and drug discovery market.


NGRL purchased a CombiMatrix custom slide biochip synthesizer and also entered a multi-year agreement to purchase additional biochips for its contract research services business.


CombiMatrix and NGRL have also entered a co-development and research agreement to "investigate various aspects of genetic analysis." Further details were not provided.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.